Blood Podcast cover image

Hodgkin lymphoma outcomes in the novel agent era, genomic safe harbors for precision T cell engineering, and a transcriptomic atlas to map imatinib resistance in CML

Blood Podcast

00:00

The Effects of Novel Agents on Outcomes and Practice Patterns

Researchers looked at a cohort of consecutive patients with relapsed or refractory classic Hodgkin lymphoma who underwent autologous transplant. Treatment approaches were quite different in the modern era of 2011 to 2020, they found. For patients transplanted in partial response, overall survival was superior in themodern era. There was a trend toward lower non-relapsed mortality in the modern Era.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app